Innate Pharma shares were up 16% to $2.25 after the company said the Food and Drug Administration has granted Breakthrough Therapy Designation to lacutamab for the treatment of adult patients with ...

Discover Stoke Therapeutics' innovative RNA-based treatments like zorevunersen for Dravet syndrome, with a promising pipeline ...

Palantir was the best-performing member of the S&P 500 ( ^GSPC -0.01%) during that period. In fact, it beat the next closest ...

Vertex Pharmaceuticals continues to execute ... conservative analyst revenue projections, making the stock a STRONG BUY with a 12-month price of $550/share. As of yesterday evening, the FDA ...

This anticipated adoption, along with a projected modest market penetration, underpins the increased price target for Vertex Pharmaceuticals’ stock, contributing to Fein’s Buy rating.

Explore Sun Pharma Industries stock price history with detailed daily historical prices, including open, high, low, and volume data. Review stock chart history to analyze past trends and find the ...

The recent settlement that would see Purdue Pharma and its owners, the Sackler family, pay $7.4 billion to resolve lawsuits filed by state and local governments across the country is a welcome ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) became a popular AI stock following NVIDIA’s $ ... its Overweight rating on RXRX shares with a price target downgrade from $12 to $10.

New York Attorney General Letitia James announced Thursday a new $7.5 billion settlement with Purdue Pharmaceuticals and the Sackler Family for their role in the ongoing US opioid crisis, with the ...

NEW YORK (Reuters) - Purdue Pharma said on Friday it needs more time to build support for a new $7.4 billion settlement that could complete the company's years-long effort to resolve thousands of ...

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...

What has been 52-week high of Bal Pharma Ltd stocks? The highest price of Bal Pharma Ltd stock is ₹157.98 in ... DATA SOURCES: Corporate data, historical price & volume data published on this ...